pharma · Refractory Focal Onset Epilepsy · Early Parkinson’s Disease
Biohaven Bioscience Ireland
Biohaven Bioscience Ireland Limited
News and analysis for Biohaven Bioscience Ireland on NovaPharmaNews — regulatory, clinical, and market coverage.
GB HQ
EMA registrant Type
Company details
- Status
- Public
- HQ
- GB
- Programs
- 7
- Drugs
- 8
- Patents
- 0
News & analysis
NovaPharmaNews articles mentioning Biohaven Bioscience Ireland — regulatory, clinical, and market coverage.
News and analysis for Biohaven Bioscience Ireland on NovaPharmaNews — regulatory, clinical, and market coverage.